LOGIN  |  REGISTER
Terns Pharmaceuticals
Amneal Pharmaceuticals

Empower Clinics Division The Medi-Collective Opens Clinic With Co-Located Rexall Pharmacy

As of Today, the New Kitchener, ON Location is Accepting Patients for Family Medicine Appointments

EMPOWER CLINICS INC. (CSE:CBDT) (Frankfurt:8EC) (OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms, a medical device company, and a high complexity medical diagnostics laboratory - is pleased to announce the opening of its next The Medi-Collective ("TMC") clinic in Kitchener, Ontario.

The 2,500 square feet location, which is co-located with a Rexall pharmacy, will offer family medicine, internal medicine and paramedical services such as chiropractor, physiotherapy, registered massage therapy and custom bracing orthotics. As of today, the clinic is accepting new patients. There are currently two family doctors and one internal medicine specialist with plans to hire additional physicians and support staff in the coming months. Empower Clinics plans to leverage its subsidiary network's products and services to offer a genuinely integrated patient experience. This includes offering patients access to products such as Kai Care specimen collection devices and MediSure diabetic management solutions.

"The opening of our Kitchener location is another step forward in our national clinic expansion strategy," said Steven McAuley, Chairman and CEO of Empower. "As much as The Medi-Collective expands access to in-demand healthcare services, its clinics are pushing the boundaries of the healthcare experience for patients. TMC patients receive truly unique patient care that puts the totality of one's health at the forefront through our relationships with pharmacies, specialties and our capacity for paramedical products and services."

"The Medi-Collective prioritizes providing truly integrative care to Canadian patients through a community-first approach," added Dr. Jordan Rabinowitz and Dr. Aviv Tsimerman. "The Kitchener location is in a prime area that stands to benefit from TMC's convenient services and partnerships."

TMC Clinic Pipeline Update

  • Operational - 6
  • In Development & Construction - 6
  • In Acquisition - 8

TMC Kitchener Clinic

Address: 537 Fredrick St. Kitchener, ON N2B 2A7
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: 519-804-4190

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

ABOUT EMPOWER

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Media:
Steven McAuley CEO
This email address is being protected from spambots. You need JavaScript enabled to view it.
604-789-2146

Investors:
Tamara Mason
Business Development & Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.
416-671-5617

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include statements regarding: the Company's plans with respect to the offering of other Empower services and products at the Kitchener clinic; and the number, timing and location of anticipated future TMC clinic openings. Such forward-looking statements are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Company may be unable to enter into definitive agreements, or close transactions with respect to, proposed future clinic openings; that due diligence with respect to anticipated clinic openings and acquisitions may not be satisfactory to the Company; risks related to delays in permitting or construction; risks related to supply chains and access to labour; that legislative changes may have an adverse effect on the Company's business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; that the Company will be able to commence and/or complete build-outs and tenants improvements for new clinics; general business, economic, competitive, political and social uncertainties; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur on the terms or in the time expected, or at all, or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page